Skip to content

Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients.

Randomized controlled trial · Clin Neurol Neurosurg · 2021. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 34119901

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients.

Hlebokazov F, Dakukina T, Potapnev M et al.
Clin Neurol Neurosurg · 2021

PubMed ID
34119901
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.